Does the binding of cyclosporine to calmodulin result in immunosuppression?

Science
S J LeGrueJ R Dedman

Abstract

The cyclosporines are a family of cyclic endecapeptides that cause a profound suppression of primary immune stimulation both in vitro and in vivo. Recently, the regulatory protein calmodulin (CaM) has been implicated as a target for cyclosporin A (CsA) binding. This study utilized two less-active isomers of CsA to evaluate the specificity and biological significance of CaM binding. The three cyclosporines exhibited equivalent in vitro binding to CaM, regardless of immunosuppressive activity. Furthermore, CaM-dependent enzyme systems were inhibited equally by active and inactive cyclosporines, but only at concentrations 100 times those necessary to block lymphocyte activation. Thus the exquisite immunosuppressive stereospecificity displayed by cyclosporine isomers is not reflected in the binding to and inhibition of CaM, suggesting that inhibition of CaM-dependent processes is not sufficient to explain the immunosuppressive activity of CsA.

References

Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R L Kincaid, M Vaughan
Jul 1, 1985·The American Journal of Physiology·N W Weisbrodt, R A Murphy
Feb 12, 1981·Biochemical and Biophysical Research Communications·B D Roufogalis
Nov 2, 1984·Science·R E HandschumacherD W Speicher
May 29, 1981·Biochemical and Biophysical Research Communications·R K Sharma, J H Wang
Sep 1, 1983·The American Journal of Physiology·M O AksoyR A Murphy
Aug 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·M KrönkeW C Greene
Dec 1, 1984·The Journal of Experimental Medicine·A Granelli-PipernoR M Steinman
May 8, 1980·Nature·A R Means, J R Dedman

❮ Previous
Next ❯

Citations

Jan 1, 1993·Cytotechnology·J M Ford, W N Hait
Oct 1, 1989·Calcified Tissue International·P J Stewart, P H Stern
Jan 1, 1988·Immunologic Research·G N Gaulton, J F Markmann
Mar 3, 1992·Biochemical Pharmacology·B RyffelB M Foxwell
Dec 1, 1992·Immunology Today·B F Erlanger
Jan 1, 1990·International Journal of Immunopharmacology·G McLachlanA W Thomson
Jul 1, 1987·Annales De L'Institut Pasteur. Immunology·B Ryffel
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L W ScheibelW K Milhous
Jan 1, 1995·Fundamental & Clinical Pharmacology·M SaminiP Hassanzadeh
Apr 1, 1992·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·G P SchincagliaL del Senno
Jun 1, 1989·Mayo Clinic Proceedings·P C de Groen
Jul 1, 1987·Annales De L'Institut Pasteur. Immunology·A D Hess, P N Colombani
Jul 1, 1987·Annales De L'Institut Pasteur. Immunology·J E Kay
Dec 1, 1990·Journal of the American Academy of Dermatology·J A Fairley
Aug 1, 1992·Seminars in Arthritis and Rheumatism·B A DijkmansA Cats
Apr 1, 1991·International Journal of Cardiology·I KingmaL C Paul
Dec 21, 1989·The New England Journal of Medicine·B D Kahan
Aug 27, 1996·Transplantation·A al KhaderM Tariq
Jan 1, 1990·Stroke; a Journal of Cerebral Circulation·J W PetersonN T Zervas
Feb 1, 1988·The British Journal of Dermatology·J D Bos
Sep 1, 1987·European Journal of Immunology·V F QuesniauxM H Van Regenmortel
Jan 1, 1991·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·T M Hassell, A F Hefti
Jan 1, 1991·The Journal of Urology·M ShabtaiM J Gonder
Jul 1, 1990·Scandinavian Journal of Immunology·J V PovlsenL U Lamm
Jan 9, 1992·Biochemical Pharmacology·P R Twentyman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.